Business Segments · Depreciation
Diabetes Group — Depreciation
Medtronic Diabetes Group — Depreciation remained flat by 0.0% to $32.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.7%, from $30.00M to $32.00M. Over 2 years (FY 2022 to FY 2025), Diabetes Group — Depreciation shows an upward trend with a 37.1% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2017
Last reportedQ1 2026
How to read this metric
An increase often reflects higher capital investment in production capacity, while a decrease may suggest aging infrastructure.
Detailed definition
This represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities...
Peer comparison
Standard depreciation expense reported by manufacturing-heavy business segments.
Metric ID:
mdt_segment_diabetes_depreciationHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.75M | $16.75M | $16.75M | $16.75M | $20.00M | $20.00M | $20.00M | $20.00M | $24.00M | $27.00M | $30.00M | $33.00M | $31.00M | $32.00M | $32.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +19.4% | +0.0% | +0.0% | +0.0% | +20.0% | +12.5% | +11.1% | +10.0% | -6.1% | +3.2% | +0.0% |
| YoY Change | — | — | — | — | +19.4% | +19.4% | +19.4% | +19.4% | +20.0% | +35.0% | — | — | +29.2% | +18.5% | +6.7% |
Range$16.75M – $33.00M
CAGR+20.3%
Avg YoY Growth+20.8%
Median YoY Growth+19.4%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's diabetes group — depreciation?
- Medtronic (MDT) reported diabetes group — depreciation of $32.00M in Q1 2026.
- How has Medtronic's diabetes group — depreciation changed year-over-year?
- Medtronic's diabetes group — depreciation increased by 6.7% year-over-year, from $30.00M to $32.00M.
- What is the long-term trend for Medtronic's diabetes group — depreciation?
- Over 2 years (2022 to 2025), Medtronic's diabetes group — depreciation has grown at a 37.1% compound annual growth rate (CAGR), from $67.00M to $126.00M.
- What does diabetes group — depreciation mean?
- The non-cash expense representing the wear and tear of equipment used to make diabetes products.